Inhibiting Glycosphingolipid Synthesis Improves Glycemic Control and Insulin Sensitivity in Animal Models of Type 2 DiabetesHongmei Zhao, Seng H. Cheng|Diabetes|2007Cited by 239
Glycoengineered Acid α-Glucosidase With Improved Efficacy at Correcting the Metabolic Aberrations and Motor Function Deficits in a Mouse Model of Pompe DiseaseYunxiang Zhu, Seng H. Cheng, Karen Lee et al.|Molecular Therapy|2009Cited by 169
Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry DiseaseJohn Marshall, Seng H. Cheng|PLoS ONE|2010Cited by 72
Correction of the Nonlinear Dose Response Improves the Viability of Adenoviral Vectors for Gene Therapy of Fabry DiseaseRobin J. Ziegler, Seng H. Cheng, Chester Li et al.|Human Gene Therapy|2002Cited by 46
Correction of Disease Phenotype in Pompe Disease Knockout Mice Following Cationic Lipid-GL-67-Mediated Gene TherapyFrank Martiniuk, Seng H. Cheng, Adra Mack et al.|DNA and cell biology reports.|2025Cited by 0